This involvement of Immutep/Goetz really is a strategic shift by...

This involvement of Immutep/Goetz really is a strategic shift by Immutep
management....It is a great example of forward thinking, just bear with
me, I'm trying to say this right .......
Immutep must have approached Goetz IMO, looking through Goetz's
recent managed takeovers and mergers, they are regularly in the billions
of dollars and euros......
Yet here they are compiling an extremely detailed and comprehensive report
of a small Aussie biotech with a MC of barely $100M auds.....
IMO, there is either something afoot or Marc is getting ahead of the curve
so Immutep is somewhat prepared if or when an approach is received....
Also interesting Goetz thinks Aipac could be nearing commercialisation
by circa 2020......In my book things are ramping up, but I could be way
off track...